Nova Leah
Cybersecurity compliance solution for medical device manufacturers and healthcare providers. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD25—38m (Dealroom.co estimates Mar 2019.)
Company register number 558845
County Louth Ireland (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 |
|---|---|---|
| EBITDA | <1m | <1m |
| Profit | <1m | <1m |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€420k | Early VC | ||
* | €3.8m | Early VC | |
| N/A | €4.2m | Early VC | |
€3.7m | Secondary | ||
| Total Funding | CAD12.6m | ||
Recent News about Nova Leah
EditMore about Nova Leah
EditNova Leah is a world leader in the provision of cybersecurity risk management solutions for medical device manufacturers and healthcare providers.
With SelectEvidence™, Nova Leah provides medical device manufacturers with an intelligent, automated and traceable approach to cybersecurity risk management.
Now, with SelectEvaluateⓇ, Nova Leah is transforming medical device third party risk management and cybersecurity monitoring across the healthcare cybersecurity supply chain. SelectEvaluateⓇ is launching in October 2023.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.